VKTX Viking Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · Lihat di SEC EDGAR ↗ tutup Okt 5, 2026 10-K/10-Q Jul 29, 2026
$29,73
· % dari rentang 52 mgg
· di atas terendah
· ke tinggi
$26,89rendah 52m
$43,15tinggi 52m
Kapitalisasi Pasar (MRQ)
$3.47B
P/E (TTM)
-6.4
EPS (TTM)
$-4.67
Pendapatan (TTM)
$0
lencana Anda
Rentang 52M
$27–$43
Peringkat Analis
BUY
Target Harga
$95
P/E
-6.4
ROE
-88.9%
Margin Laba Bersih
·
Strip lencana Anda kosong — sematkan metrik di mana saja di halaman ini.
VKTX Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$29.73
Kapitalisasi Pasar (MRQ)
$3.47B
P/E (TTM)
-6.4
EPS (TTM)
$-4.67
Pendapatan (TTM)
$0
ROE (TTM)
-88.9%
Rentang 52M
$27–$43
VKTX Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
rentang
batang
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan$02016-12-31 → 2025-12-31
EPS$-3.192021-12-31 → 2025-12-31
Valuasi & Rasio
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
| Metrik | Tren 5 Tahun | VKTX | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| P/E (TTM) | -6.4rata-rata 5T ≈-17.6 | ≈-17.6 | · | · | |
| P/B (MRQ) | 8.5rata-rata 5T ≈4.7 | ≈4.7 | 4.0 | Terlalu mahal | |
| Price / Cash Flow (Harga / Arus Kas) | -12.2rata-rata 5T ≈-22.8 | ≈-22.8 | · | · | |
| Price / Tangible Book (Harga / Nilai Buku Berwujud) | 5.3rata-rata 5T ≈4.7 | ≈4.7 | · | · |
Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
| Metrik | Tren 5 Tahun | VKTX | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| ROA (TTM) | -79.2%rata-rata 5T ≈-30.7% | ≈-30.7% | -17.4% | Lemah | |
| ROE (TTM) | -88.9%rata-rata 5T ≈-32.9% | ≈-32.9% | -29.1% | Lemah | |
| ROIC | -61.6% | · | -14.3% | Lemah |
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
| Metrik | Tren 5 Tahun | VKTX | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Rasio Lancar (MRQ) | 4.7rata-rata 5T ≈18.6 | ≈18.6 | 9.0 | Likuiditas rendah | |
| Quick Ratio (Rasio Cepat) | 2.2rata-rata 5T ≈2.1 | ≈2.1 | 4.0 | Likuiditas rendah |
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Belum ada data untuk grup rasio ini
Data fundamental belum cukup untuk menghitung grup rasio ini.
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
| Metrik | Tren 5 Tahun | VKTX | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Asset Turnover (Perputaran Aset) | 0.0rata-rata 5T ≈0.0 | ≈0.0 | 0.3 | Lemah | |
| Revenue / Employee (Pendapatan Tahunan ÷ karyawan (jumlah karyawan, yfinance). Turunan — bukan konsep SEC-XBRL yang tersimpan.) | ≈$0.00 | · | · | · |
nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
-23.1%
Laporan Berikutnya
Okt 20, 2026
| Periode | Laporan | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|---|
| 30 Juni 2026 | Jul 21, 2026 | $-1.10 | $-1.27 | 13.5% |
| 31 Maret 2026 | $-1.37 | $-1.03 | -32.5% | |
| 31 Des. 2025 | $-1.38 | $-0.91 | -51.3% | |
| 30 Sep. 2025 | $-0.81 | $-0.69 | -17.2% | |
| 30 Juni 2025 | $-0.58 | $-0.46 | -27.4% | |
| 31 Maret 2025 | $-0.41 | $-0.33 | -23.9% |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| R&D Expense | $345M | $102M | $64M | $54M | $45M | $32M | $24M | $19M | $14M | $9M | $7M | $22M | |
| SG&A Expense | $48M | $49M | $37M | $16M | $11M | $11M | $9M | $7M | $5M | $5M | $5M | $1M | |
| Operating Expenses | $393M | $151M | $101M | $70M | $56M | $43M | $33M | $26M | $19M | $14M | $12M | $23M | |
| Operating Income | $-393M | $-151M | $-101M | $-70M | $-56M | $-43M | $-33M | $-26M | $-19M | $-14M | $-12M | $-23M | |
| Other Non-op | $34M | $41M | $15M | $1M | $692.0K | $3M | $7M | $4M | $-2M | $-884.5K | $-11M | $2M | |
| Pretax Income | $-360M | $-110M | $-86M | · | · | · | · | · | · | · | · | · | |
| Income Tax | $1.0K | $1.0K | $1.0K | $1.0K | $2.0K | $0 | $0 | $0 | $0 | $0 | · | · | |
| Net Income | $-360M | $-110M | $-86M | $-69M | $-55M | $-39M | $-26M | $-22M | $-21M | $-15M | $-23M | $-22M | |
| EPS (Basic) | $-3.19 | $-1.01 | $-0.91 | $-0.90 | $-0.71 | · | · | · | · | · | · | · | |
| EPS (Diluted) | $-3.19 | $-1.01 | $-0.91 | $-0.90 | $-0.71 | · | · | · | · | · | · | · | |
| Shares (Basic) | 112,667,000 | 109,037,000 | 94,347,000 | 76,834,000 | 77,198,000 | · | · | · | · | · | · | · | |
| Shares (Diluted) | 112,667,000 | 109,037,000 | 94,347,000 | 76,834,000 | 77,198,000 | · | · | · | · | · | · | · | |
| EBITDA | $-393M | $-151M | $-101M | $-70M | $-56M | $-43M | $-33M | $-26M | $-19M | $-14M | $-12M | · |
Neraca
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $166M | $27M | $56M | $37M | $26M | $29M | $8M | $25M | $9M | $3M | $768.5K | $755.9K | |
| Short-term Investments | · | · | · | · | · | $219M | $267M | $277M | $12M | $10M | $13M | · | |
| Prepaid Expense | $2M | $1M | $3M | $3M | $619.0K | $442.0K | $405.0K | $278.0K | $389.0K | $282.7K | $1M | $17.8K | |
| Current Assets | $716M | $907M | $367M | $167M | $211M | $256M | $284M | $302M | $22M | $14M | $15M | $773.7K | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | · | · | · | $775 | |
| Total Assets | $716M | $908M | $368M | $169M | $211M | $257M | $284M | $302M | $22M | $15M | $15M | $3M | |
| Accounts Payable | $53M | $10M | $8M | $9M | $1M | $4M | $2M | $959.0K | $2M | $1M | $592.4K | $2M | |
| Current Liabilities | $77M | $27M | $19M | $22M | $9M | $12M | $7M | $5M | $9M | $6M | $2M | $23M | |
| Capital Leases | $0 | $630.0K | $936.0K | $1M | · | $29.0K | $360.0K | · | · | · | · | · | |
| Total Liabilities | $77M | $28M | $20M | $23M | $9M | $12M | $7M | $5M | $9M | $6M | $7M | $25M | |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $358 | $208 | $97 | $60 | |
| Retained Earnings | $-848M | $-488M | $-378M | $-292M | $-223M | $-168M | $-129M | $-103M | $-81M | $-60M | $-46M | $-22M | |
| Treasury Stock | $0 | $0 | $7M | $7M | · | · | · | · | · | · | · | · | |
| Stockholders' Equity | $639M | $880M | $348M | $145M | $202M | $244M | $277M | $298M | $13M | $8M | $9M | $-22M | |
| Liabilities + Equity | $716M | $908M | $368M | $169M | $211M | $257M | $284M | $302M | $22M | $15M | $15M | $3M | |
| Shares Outstanding | 114,793,067 | 111,573,519 | 100,113,770 | 78,257,258 | 78,248,401 | 73,215,940 | 72,413,602 | 71,742,043 | 35,817,104 | 20,823,873 | 9,683,741 | 6,000,000 |
Arus Kas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $41M | $30M | $17M | $9M | $6M | $6M | $4M | $3M | $1M | $2M | $3M | $6.3K | |
| Operating Cash Flow | $-279M | $-88M | $-73M | $-48M | $-48M | $-22M | $-25M | $-19M | $-15M | $-11M | $-9M | $-2M | |
| Investing Cash Flow | $341M | $-553M | $-179M | $55M | $38M | $42M | $7M | $-266M | $-2M | · | · | · | |
| Stock Issued | · | · | · | · | · | · | · | $297M | $22M | $12M | $25M | · | |
| Stock Repurchased | · | · | · | $7M | · | · | · | · | · | $229 | $38 | $2 | |
| Net Stock Activity | · | · | · | $-7M | · | · | · | $297M | $22M | $12M | $25M | · | |
| Financing Cash Flow | $76M | $612M | $271M | $4M | $7M | $950.0K | $887.0K | $300M | $22M | · | · | · | |
| Net Change in Cash | · | · | · | $11M | $-3M | $21M | $-16M | $16M | $6M | $2M | $12.7K | $576.2K |
Profitabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -44.3% | -17.2% | -32.0% | -36.3% | -23.5% | -14.6% | -8.8% | -13.6% | -112.3% | -98.3% | -253.3% | · | |
| ROE | -47.3% | -17.9% | -34.8% | -39.7% | -24.6% | -15.2% | -9.0% | -14.2% | -191.3% | -175.7% | 349.2% | · | |
| ROIC | -61.6% | · | · | · | · | · | · | · | · | · | · | · |
Likuiditas & Solvabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.3 | 33.1 | 19.2 | 7.6 | 24.0 | 21.1 | 41.8 | 66.4 | 2.5 | 2.2 | 7.7 | · | |
| Quick Ratio | 2.2 | 1.0 | 2.9 | 1.7 | 3.0 | 20.5 | 40.7 | 66.3 | 2.4 | 2.0 | 7.1 | · |
Efisiensi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · |
Per Saham
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $5.57 | $7.89 | $3.48 | $1.86 | $2.58 | $3.34 | $3.83 | $4.15 | $0.38 | $0.39 | $0.90 | · | |
| Revenue / Share | $0.00 | $0.00 | $0.00 | $0.00 | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | $-2.47 | $-0.81 | $-0.78 | $-0.63 | · | · | · | · | · | · | · | · | |
| Cash / Share | $1.44 | $0.24 | $0.55 | $0.47 | $0.34 | $0.40 | $0.12 | $0.35 | $0.25 | $0.15 | $0.08 | · | |
| EPS (TTM) | $-3.19 | $-1.01 | $-0.91 | $-0.90 | $-0.71 | · | · | · | · | · | · | · |
Valuasi (TTM)
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | |
| Net Income TTM | $-360M | $-110M | $-86M | $-69M | $-55M | $-39M | $-26M | $-22M | $-21M | $-15M | $-23M | · | |
| Market Cap | $4.04B | $4.49B | $1.86B | $736M | $360M | $412M | $581M | $549M | $145M | $25M | $33M | · | |
| P/E | -11.0 | -39.8 | -20.5 | -10.4 | -6.5 | · | · | · | · | · | · | · | |
| P/B | 6.3 | 5.1 | 5.3 | 5.1 | 1.8 | 1.7 | 2.1 | 1.8 | 10.8 | 3.1 | 3.8 | · | |
| P / Tangible Book | 6.3 | 5.1 | 5.3 | 5.1 | 1.8 | 1.7 | · | · | · | · | · | · | |
| P / Cash Flow | -14.5 | -51.1 | -25.4 | -15.2 | -7.6 | -18.9 | -23.5 | -29.3 | -9.9 | -2.2 | -3.8 | · | |
| Earnings Yield | -9.1% | -2.5% | -4.9% | -9.6% | -15.4% | · | · | · | · | · | · | · |
Laporan Laba Rugi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| R&D Expense | $116M | $150M | $153M | $90M | $60M | $41M | $31M | $23M | $24M | $24M | $18M | $14M | $11M | $12M | $14M | $13M | |
| SG&A Expense | $17M | $14M | $11M | $9M | $14M | $14M | $15M | $14M | $10M | $10M | $9M | $10M | $10M | $4M | $4M | $4M | |
| Operating Expenses | $133M | $164M | $165M | $99M | $75M | $55M | $46M | $37M | $34M | $34M | $27M | $24M | $21M | $16M | $18M | $16M | |
| Operating Income | $-133M | $-164M | $-165M | $-99M | $-75M | $-55M | $-46M | $-37M | $-34M | $-34M | $-27M | $-24M | $-21M | $-16M | $-18M | $-16M | |
| Other Non-op | $5M | $6M | $7M | $8M | $9M | $10M | $11M | $12M | $12M | $7M | $5M | $5M | $1M | $423.0K | $199.0K | $142.0K | |
| Net Income | $-128M | $-158M | $-158M | $-91M | $-66M | $-46M | $-35M | $-25M | $-22M | $-27M | $-23M | $-19M | $-20M | $-16M | $-17M | $-16M | |
| EPS (Basic) | $-1.10 | $-1.37 | $-1.39 | $-0.81 | $-0.58 | $-0.41 | $-0.33 | $-0.22 | $-0.20 | $-0.26 | $-0.23 | $-0.19 | $-0.25 | $-0.21 | $-0.23 | $-0.21 | |
| EPS (Diluted) | $-1.10 | $-1.37 | $-1.39 | $-0.81 | $-0.58 | $-0.41 | $-0.33 | $-0.22 | $-0.20 | $-0.26 | $-0.23 | $-0.19 | $-0.25 | $-0.21 | $-0.23 | $-0.21 | |
| Shares (Basic) | 116,263,000 | 115,568,000 | · | 112,320,000 | 112,134,000 | 112,069,000 | · | 110,911,000 | 110,390,000 | 103,457,000 | 99,846,000 | 99,010,000 | 78,352,000 | 76,505,000 | 76,842,000 | 77,413,000 | |
| Shares (Diluted) | 116,263,000 | 115,568,000 | · | 112,320,000 | 112,134,000 | 112,069,000 | · | 110,911,000 | 110,390,000 | 103,457,000 | 99,846,000 | 99,010,000 | 78,352,000 | 76,505,000 | 76,842,000 | 77,413,000 | |
| EBITDA | $-133M | $-164M | · | $-99M | $-75M | $-55M | · | $-37M | $-34M | $-34M | $-27M | $-24M | $-21M | $-16M | $-18M | $-16M |
Neraca
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $126M | $118M | $166M | $100M | $34M | $38M | $27M | $50M | $44M | $196M | $37M | $70M | $18M | $29M | $16M | $12M | |
| Prepaid Expense | $941.0K | $1M | $2M | $2M | $3M | $865.0K | $1M | $2M | $138.0K | $643.0K | $670.0K | $960.0K | $4M | $956.0K | $1M | $388.0K | |
| Current Assets | $518M | $608M | $716M | $739M | $827M | $866M | $907M | $937M | $946M | $966M | $381M | $399M | $149M | $165M | $180M | $193M | |
| Total Assets | $522M | $608M | $716M | $739M | $828M | $867M | $908M | $938M | $947M | $968M | $383M | $401M | $151M | $167M | $182M | $195M | |
| Accounts Payable | $69M | $67M | $53M | $4M | $5M | $8M | $10M | $254.0K | $11M | $5M | $6M | $6M | $4M | $3M | $6M | $3M | |
| Current Liabilities | $110M | $106M | $77M | $26M | $32M | $20M | $27M | $26M | $25M | $33M | $13M | $13M | $16M | $14M | $15M | $11M | |
| Capital Leases | $4M | $0 | $0 | $318.0K | $410.0K | $502.0K | $630.0K | $755.0K | $766.0K | $852.0K | $1M | $1M | $1M | $1M | $1M | $1M | |
| Total Liabilities | $114M | $106M | $77M | $26M | $32M | $20M | $28M | $26M | $26M | $34M | $14M | $15M | $17M | $15M | $16M | $13M | |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | |
| Retained Earnings | $-1.13B | $-1.01B | $-848M | $-690M | $-599M | $-534M | $-488M | $-452M | $-428M | $-405M | $-353M | $-331M | $-312M | $-272M | $-257M | $-239M | |
| Treasury Stock | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $7M | $7M | $7M | $7M | $7M | $5M | |
| Stockholders' Equity | $408M | $502M | $639M | $713M | $795M | $847M | $880M | $911M | $921M | $934M | $368M | $386M | $134M | $151M | $165M | $182M | |
| Liabilities + Equity | $522M | $608M | $716M | $739M | $828M | $867M | $908M | $938M | $947M | $968M | $383M | $401M | $151M | $167M | $182M | $195M | |
| Shares Outstanding | 116,652,937 | 115,893,943 | 114,793,067 | 112,446,961 | 112,329,709 | 112,288,759 | 111,573,519 | 111,434,821 | 110,796,200 | 110,228,869 | 100,028,828 | 100,028,828 | 79,319,081 | 76,688,478 | 76,688,478 | 77,373,712 |
Arus Kas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $11M | $10M | $9M | $7M | $14M | $11M | $6M | $9M | $7M | $8M | $4M | $5M | $4M | $2M | $2M | $2M | |
| Operating Cash Flow | $-125M | $-114M | $-85M | $-94M | $-47M | $-52M | $-31M | $-22M | $-29M | $-6M | $-20M | $-11M | $-25M | $-13M | $-13M | $-11M | |
| Investing Cash Flow | $109M | $54M | $76M | $160M | $43M | $63M | $7M | $26M | $-126M | $-460M | $-13M | $-204M | $2M | $27M | $19M | $2M | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $2M | $5M | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-5M | |
| Financing Cash Flow | $24M | $12M | $75M | $480.0K | $507.0K | $349.0K | $1M | $3M | $3M | $606M | $-74.0K | $267M | $4M | $10.0K | $-2M | $-5M | |
| Net Change in Cash | · | · | · | · | · | · | · | · | · | · | · | $51M | $-18M | $13M | $4M | $-14M |
Profitabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -19.0% | -21.5% | · | -10.8% | -7.4% | -5.0% | · | -3.8% | -3.3% | -4.9% | -8.2% | -6.6% | -11.3% | -8.1% | -8.3% | -7.2% | |
| ROE | -21.3% | -23.5% | · | -11.2% | -7.6% | -5.1% | · | -3.9% | -3.4% | -5.1% | -8.7% | -7.0% | -12.3% | -8.7% | -8.9% | -7.7% |
Likuiditas & Solvabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.7 | 5.7 | · | 28.3 | 25.9 | 44.2 | · | 36.5 | 37.7 | 29.5 | 28.4 | 29.6 | 9.6 | 11.7 | 12.1 | 17.2 | |
| Quick Ratio | 1.1 | 1.1 | · | 3.9 | 1.1 | 1.9 | · | 2.0 | 1.8 | 6.0 | 2.8 | 5.2 | 1.2 | 2.1 | 1.1 | 1.1 |
Efisiensi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Per Saham
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $3.50 | $4.33 | · | $6.34 | $7.08 | $7.54 | · | $8.18 | $8.31 | $8.47 | $3.68 | $3.86 | $1.69 | $1.97 | $2.15 | $2.36 | |
| Revenue / Share | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | · | |
| Cash Flow / Share | · | $-0.99 | · | · | · | $-0.47 | · | · | · | $-0.06 | · | · | $-0.31 | · | · | · | |
| Cash / Share | $1.08 | $1.02 | · | $0.89 | $0.30 | $0.34 | · | $0.45 | $0.40 | $1.77 | $0.37 | $0.69 | $0.23 | $0.38 | $0.21 | $0.16 | |
| EPS (TTM) | $-4.67 | $-4.15 | · | $-2.13 | $-1.54 | $-1.16 | · | $-0.92 | $-0.93 | $-0.92 | $-0.92 | $-0.90 | $-0.94 | $-0.81 | $-0.77 | $-0.74 |
Valuasi (TTM)
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income TTM | $-535M | $-472M | · | $-237M | $-172M | $-128M | · | $-99M | $-97M | $-94M | $-81M | $-74M | $-72M | $-62M | $-59M | $-57M | |
| Market Cap | $4.55B | $3.77B | · | $2.96B | $2.98B | $2.71B | · | $7.05B | $5.87B | $9.04B | $1.11B | $1.62B | $1.32B | $209M | $222M | $232M | |
| P/E | -8.4 | -7.8 | · | -12.3 | -17.2 | -20.8 | · | -68.8 | -57.0 | -89.1 | -12.0 | -18.0 | -17.7 | -3.4 | -3.8 | -4.1 | |
| P/B | 11.1 | 7.5 | · | 4.1 | 3.7 | 3.2 | · | 7.7 | 6.4 | 9.7 | 3.0 | 4.2 | 9.9 | 1.4 | 1.3 | 1.3 | |
| P / Tangible Book | 11.1 | 7.5 | · | 4.1 | 3.7 | 3.2 | · | 7.7 | 6.4 | 9.7 | 3.0 | 4.2 | 9.9 | 1.4 | 1.3 | 1.3 | |
| P / Cash Flow | · | -33.1 | · | · | · | -51.8 | · | · | · | -1473.6 | · | · | -53.6 | · | · | -22.0 | |
| Earnings Yield | -12.0% | -12.8% | · | -8.1% | -5.8% | -4.8% | · | -1.5% | -1.8% | -1.1% | -8.3% | -5.5% | -5.7% | -29.8% | -26.6% | -24.7% |
Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Pendapatan | $0 | $0 | $0 | $0 | $0 |
| Laba Bersih | $-360M | $-110M | $-86M | $-69M | $-55M |
| EPS Dilusian | $-3.19 | $-1.01 | $-0.91 | $-0.90 | $-0.71 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Rasio Lancar | 9.3 | 33.1 | 19.2 | 7.6 | 24.0 |
| Rasio Cepat | 2.2 | 1.0 | 2.9 | 1.7 | 3.0 |
Tidak ada data untuk laporan ini
Data fundamental belum cukup untuk membuat laporan ini.
Pemilik institusional (13F) 499 pengaju · $3.8B total · Per tanggal 30 Sep. 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Pemegang
499
Nilai yang dipegang
$3.8B
Posisi baru
84
Posisi yang keluar
44
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 84 (+8 vs Kuartal sebelumnya) | 44 (-25 vs Kuartal sebelumnya) | 153 (-5 vs Kuartal sebelumnya) | 133 (+4 vs Kuartal sebelumnya) | +5.8M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| VANGUARD GROUP INC | $351.254.252 | 9.984.487 | 9,30% | Saham |
| FMR LLC | $247.157.830 | 6.335.756 | 6,54% | Saham |
| BlackRock, Inc. | $241.458.213 | 6.189.649 | 6,39% | Saham |
| STATE STREET CORP | $218.705.430 | 5.606.394 | 5,79% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $197.143.394 | 5.053.663 | 5,22% | Saham |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $174.931.100 | 4.484.263 | 4,63% | Saham |
| TWO SIGMA INVESTMENTS, LP | $153.598.520 | 3.937.414 | 4,07% | Saham |
| MORGAN STANLEY | $135.990.439 | 3.486.040 | 3,60% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $113.382.565 | 2.906.500 | 3,00% | Opsi beli |
| AMERIPRISE FINANCIAL INC | $84.108.797 | 2.156.083 | 2,23% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $81.865.360 | 2.097.981 | 2,17% | Saham |
| TWO SIGMA ADVISERS, LP | $74.906.241 | 2.129.228 | 1,98% | Saham |
| AMERICAN CENTURY COMPANIES INC | $70.844.186 | 1.816.050 | 1,88% | Saham |
| D. E. Shaw & Co., Inc. | $62.649.826 | 1.605.994 | 1,66% | Saham |
| DIADEMA PARTNERS LP | $47.623.408 | 1.220.800 | 1,26% | Opsi beli |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $46.039.602 | 1.180.200 | 1,22% | Opsi jual |
| CITADEL ADVISORS LLC | $43.773.121 | 1.122.100 | 1,16% | Opsi beli |
| BNP PARIBAS FINANCIAL MARKETS | $38.296.117 | 981.700 | 1,01% | Saham |
| CITADEL ADVISORS LLC | $37.118.600 | 951.515 | 0,98% | Saham |
| GOLDMAN SACHS GROUP INC | $36.780.227 | 942.841 | 0,97% | Saham |
| UBS Group AG | $36.515.505 | 936.055 | 0,97% | Saham |
| JPMORGAN CHASE & CO | $36.387.793 | 915.185 | 0,96% | Saham |
| JANE STREET GROUP, LLC | $35.091.757 | 899.558 | 0,93% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $31.846.477 | 816.367 | 0,84% | Saham |
| RAYMOND JAMES FINANCIAL INC | $30.999.667 | 794.660 | 0,82% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $28.557.153 | 732.047 | 0,76% | Saham |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $28.504.217 | 730.690 | 0,75% | Saham |
| Pictet Asset Management Holding SA | $26.640.280 | 682.909 | 0,71% | Saham |
| Vestal Point Capital, LP | $26.526.800 | 680.000 | 0,70% | Saham |
| NORTHERN TRUST CORP | $24.448.309 | 626.719 | 0,65% | Saham |
| CITADEL ADVISORS LLC | $23.530.832 | 603.200 | 0,62% | Opsi jual |
| Eversept Partners, LP | $23.519.987 | 602.922 | 0,62% | Saham |
| BlackBarn Capital Partners LP | $23.406.000 | 600.000 | 0,62% | Saham |
| Jump Financial, LLC | $22.621.196 | 579.882 | 0,60% | Saham |
| ADAR1 Capital Management, LLC | $22.393.222 | 574.038 | 0,59% | Saham |
| DIMENSIONAL FUND ADVISORS LP | $21.067.468 | 540.053 | 0,56% | Saham |
| JANE STREET GROUP, LLC | $20.870.350 | 535.000 | 0,55% | Opsi beli |
| Connor, Clark & Lunn Investment Management Ltd. | $20.698.979 | 530.607 | 0,55% | Saham |
| Caption Management, LLC | $20.511.458 | 525.800 | 0,54% | Opsi beli |
| TANG CAPITAL MANAGEMENT LLC | $19.505.000 | 500.000 | 0,52% | Saham |
| MILLENNIUM MANAGEMENT LLC | $19.433.690 | 498.172 | 0,51% | Saham |
| PRINCIPAL FINANCIAL GROUP INC | $19.290.796 | 494.509 | 0,51% | Saham |
| Point72 Asset Management, L.P. | $18.463.745 | 473.308 | 0,49% | Saham |
| Clearbridge Investments, LLC | $17.350.907 | 444.781 | 0,46% | Saham |
| DIADEMA PARTNERS LP | $17.234.930 | 441.808 | 0,46% | Saham |
| BLAIR WILLIAM & CO/IL | $16.258.035 | 416.766 | 0,43% | Saham |
| Bank of New York Mellon Corp | $15.909.848 | 407.840 | 0,42% | Saham |
| ExodusPoint Capital Management, LP | $15.346.650 | 393.000 | 0,41% | Opsi beli |
| BANK OF AMERICA CORP /DE/ | $14.971.064 | 383.775 | 0,40% | Saham |
| Walleye Trading LLC | $14.964.236 | 383.600 | 0,40% | Opsi beli |
Orang dalam perusahaan 17 orang dalam · 9 pejabat · 8 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Brian Lian | President & CEO | 29 Juli 2026 S | 2.572.441 | 0 | 6 | $-14.005.897 |
| Greg Zante | Chief Financial Officer | 29 Juli 2026 S | 212.204 | 0 | 6 | $-2.823.737 |
| Marianna Mancini | Chief Operating Officer | 29 Juli 2026 S | 422.760 | 0 | 6 | $-2.727.473 |
| Michael Dinerman | Chief Operating Officer | 4 Mei 2015 C | 694.116 | 0 | 0 | $0 |
| Hubert C Chen | Chief Medical Officer | 1 Juni 2026 A | · | 0 | 0 | $0 |
| Neil William Aubuchon | Chief Commercial Officer | 10 Maret 2026 P | 4.475 | 1 | 0 | $149.912 |
| Michael Morneau | VP, Finance and Administration | 19 Jan. 2021 F | 116.062 | 0 | 0 | $0 |
| Hiroko Masamune | Chief Development Officer | 3 Jan. 2019 A | 141.063 | 0 | 0 | $0 |
| Rochelle Hanley | Chief Medical Officer | 4 Mei 2016 F | 160.836 | 0 | 0 | $0 |
| Dorothy Elizabeth Kelly-Gemmell | Direktur | 1 Agu 2026 A | 6.333 | 0 | 0 | $0 |
| Sarah Kathryn Rouan | Direktur | 2 Jan. 2026 A | 4.390 | 0 | 0 | $0 |
| Lawson Macartney | Direktur | 2 Jan. 2026 A | 51.115 | 0 | 0 | $0 |
| Charles A Rowland Jr | Direktur | 2 Jan. 2026 A | 33.150 | 0 | 1 | $-2.134.200 |
| Matthew J Singleton | Direktur | 2 Jan. 2026 A | 12.650 | 0 | 0 | $0 |
| Matthew W Foehr | Direktur | 2 Jan. 2026 A | 135.186 | 0 | 1 | $-561.760 |
| Stephen W Webster | Direktur | 2 Jan. 2020 A | 8.000 | 0 | 0 | $0 |
| Ligand Pharmaceuticals Incorporated | Pemilik 10% | 26 Agu 2020 S | 5.819.383 | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Kepemilikan ETF Dimiliki oleh 45 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| LABU · Direxion Shares ETF Trust | 0,78% | 121.599 NS | 31 Juli 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,74% | 10.811 NS | 31 Juli 2026 | N-PORT |
| ESSC · Strategy Shares | 0,31% | 3.463 NS | 31 Juli 2026 | N-PORT |
| PWS · Pacer Funds Trust | 0,22% | 1.661 NS | 31 Juli 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,15% | 4.217 NS | 31 Juli 2026 | N-PORT |
| FFSM · FIDELITY COVINGTON TRUST | 0,15% | 69.539 NS | 31 Juli 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,14% | 29.780 NS | 31 Juli 2026 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0,12% | 1.464.336 SH | 19 Agu 2026 | Harian |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,09% | 23.527 SH | 2 Okt. 2026 | Harian |
| VHT · VANGUARD WORLD FUND | 0,06% | 330.703 SH | 19 Agu 2026 | Harian |
| IYH · iShares Trust | 0,06% | 66.102 SH | 11 Sep. 2026 | Harian |
| ESML · iShares Trust | 0,06% | 50.114 SH | 11 Sep. 2026 | Harian |
| ISCG · iShares Trust | 0,05% | 16.143 SH | 11 Sep. 2026 | Harian |
| FHLC · FIDELITY COVINGTON TRUST | 0,05% | 52.319 NS | 31 Juli 2026 | N-PORT |
| SMMD · iShares Trust | 0,05% | 60.016 SH | 11 Sep. 2026 | Harian |
| VXF · VANGUARD INDEX FUNDS | 0,05% | 1.332.828 SH | 19 Agu 2026 | Harian |
| VB · VANGUARD INDEX FUNDS | 0,05% | 2.530.231 SH | 19 Agu 2026 | Harian |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,04% | 37.316 SH | 2 Okt. 2026 | Harian |
| IWS · iShares Trust | 0,03% | 156.686 SH | 11 Sep. 2026 | Harian |
| WSML · iShares Trust | 0,03% | 6.550 SH | 11 Sep. 2026 | Harian |
| IWR · iShares Trust | 0,03% | 462.379 SH | 11 Sep. 2026 | Harian |
| VTI · VANGUARD INDEX FUNDS | 0,01% | 3.501.108 SH | 19 Agu 2026 | Harian |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,01% | 19.254 SH | 19 Agu 2026 | Harian |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 63.630 SH | 19 Agu 2026 | Harian |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,01% | 9.458 SH | 19 Agu 2026 | Harian |
| DFAS · Dimensional ETF Trust | 0,01% | 48.216 NS | 31 Juli 2026 | N-PORT |
| ESGV · VANGUARD WORLD FUND | 0,01% | 25.563 SH | 19 Agu 2026 | Harian |
| IWD · iShares Trust | 0,01% | 234.063 SH | 11 Sep. 2026 | Harian |
| REVS · Columbia ETF Trust I | 0,01% | 922 NS | 31 Juli 2026 | N-PORT |
| IWP · iShares Trust | 0,01% | 46.707 SH | 11 Sep. 2026 | Harian |
| ITOT · iShares Trust | 0,01% | 158.911 SH | 11 Sep. 2026 | Harian |
| RECS · Columbia ETF Trust I | 0,01% | 9.430 NS | 31 Juli 2026 | N-PORT |
| IWB · iShares Trust | 0,00% | 73.105 SH | 11 Sep. 2026 | Harian |
| IWV · iShares Trust | 0,00% | 28.131 SH | 10 Sep. 2026 | Harian |
| TILT · FlexShares Trust | 0,00% | 1.106 NS | 31 Juli 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 9.683 NS | 31 Juli 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 1.044 NS | 31 Juli 2026 | N-PORT |
| IWF · iShares Trust | 0,00% | 33.127 SH | 11 Sep. 2026 | Harian |
| DFAU · Dimensional ETF Trust | 0,00% | 1.939 NS | 31 Juli 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 6.609 NS | 31 Juli 2026 | N-PORT |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,00% | 92.569 SH | 19 Agu 2026 | Harian |
| VONG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 12.830 SH | 19 Agu 2026 | Harian |
| ISCB · iShares Trust | · | 4.916 SH | 11 Sep. 2026 | Harian |
| ISCV · iShares Trust | · | 12.964 SH | 11 Sep. 2026 | Harian |
| SMLF · iShares Trust | · | 40.261 SH | 11 Sep. 2026 | Harian |
VKTX Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
peringkat · 26 analis
BELI
Target median
$95.00
+219,5%
9 34,6%
Beli Kuat
14 53,8%
Beli
3 11,5%
Tahan
0 0,0%
Jual
0 0,0%
Jual Kuat
Target Harga 12 Bulan
19 analis · 2026-09-30Target rata-rata $94.82 +218,9%
← Di bawah semua target
Harga saat ini $29.73
Rendah$38.00
Rata-rata$94.82
Tinggi$125.00
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| VKTX | $4.04B | -11.0 | · | · | -47.3% | · |
| RLAY | $1.47B | -5.3 | 53.4% | -1800.6% | -44.9% | · |
| TNGX | $1.20B | -10.2 | 48.3% | -162.8% | -42.2% | · |
| LEGN | · | -26.8 | · | · | -29.1% | · |
| PBLS | · | · | · | · | · | · |
| VCYT | $3.34B | 51.3 | 16.0% | 12.8% | 5.2% | 70.1% |
| IDYA | $3.04B | -27.0 | 3024.4% | -52.0% | -11.5% | · |
| CELC | $4.81B | -26.3 | · | · | -244.3% | · |
Berita Terbaru Berita utama terbaru yang menyebutkan perusahaan ini
VKTX Stock Soars as Viking Therapeutics Announces Positive GLP-1 Trial Results
Yahoo Finance · 1 minggu, 4 hari lalu
Set Yourself Up for a Strong 2027: 2 Pharmaceutical Stocks to Buy in September
Nasdaq · 3 minggu, 3 hari lalu
2 Beaten-Down Stocks With Massive Upside Potential
Nasdaq · 2 bulan, 3 minggu lalu
Is Viking Therapeutics Stock a No-Brainer Buy Below $35?
Nasdaq · 3 bulan, 1 minggu lalu
Is Viking Therapeutics Stock Going to $100?
Nasdaq · 3 bulan, 3 minggu lalu
Why 1 Wall Street Analyst Thinks Viking Therapeutics Stock Could Soar 188%
Nasdaq · 3 bulan, 3 minggu lalu
1 Alasan Saham Biotech Ini Bisa Tiga Kali Lipat Sebelum Akhir Tahun
Nasdaq · 6 bulan lalu
Apakah Anda Punya $1.500? Apakah Lebih Baik Membeli Bitcoin, atau Viking Therapeutics?
Nasdaq · 6 bulan, 1 minggu lalu
Apa yang Perlu Diketahui Tentang Pengembang Obat Obesitas Ini yang Baru Saja Mendapatkan Investasi Baru Senilai $7 Juta
Yahoo Finance · 6 bulan, 2 minggu lalu
Sinyal Perdagangan Sinyal beli/jual terbaru dengan harga masuk dan rasio risiko/imbalan
Tidak ada sinyal terbuka saat ini — tidak ada kartu yang terisi, dan itu jujur.
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Sumber: SEC 10-Q diajukan Jul 29, 2026